Our Company
About Medinice
Medinice S.A. is a medical technology company founded in 2012. It was established to develop innovative medical devices that meet market needs. The company creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery that improve patients' quality of life. Its portfolio includes several projects at various stages of development, with potential applications worldwide.
Our Mission
Our Mission
At Medinice, our mission is to harness the power of innovation to advance medical technology and improve the lives of patients with cardiovascular diseases.
We design, develop, and deliver breakthrough medical devices that meet the critical needs of patients with heart conditions. Led by physicians, engineers, and medical experts, we turn cutting-edge research into practical solutions that improve cardiovascular care. From concept to clinical use, our in-house technologies prioritize precision, safety, and lasting impact. Our expanding portfolio addresses various heart conditions, helping clinicians treat patients more effectively and reliably.
Our Leadership
Founded by visionary leaders Sanjeev Choudhary and Professor Piotr Suwalski, Medinice is committed to advancing cardiovascular care through medical innovation. Sanjeev Choudhary brings deep expertise in corporate strategic leadership and healthcare entrepreneurship, while Professor Suwalski, a leading cardiac surgeon and academic, provides top-tier clinical and scientific insight. Together, they have built a multidisciplinary team of physicians, engineers, and experts focused on developing breakthrough technologies that improve the lives of heart disease patients.
Meet our team
We develop novel medical devices
We develop novel medical devices
Medinice develops minimally invasive medical devices aimed at enhancing outcomes in cardiology and cardiac surgery. Our advanced products - including PacePress compression dressing, CoolCryo cryoablation system, AtriClamp stroke prevention clip and MiniMax dual-function catheter - have the potential to improve procedural precision and accelerate patient recovery. Backed by strong research and multiple patents, Medinice focuses on delivering effective, practical solutions for cardiac care.
More about our products
We are a public company
We are a public company
Medinice S.A. shares debuted on NewConnect on September 25, 2018, and on December 30, 2020, the company moved to the Main Market of the Warsaw Stock Exchange—an important milestone in its growth and visibility. Listed under the ticker ICE (ISIN: PLMDNCE00016), Medinice operates in the medical device sector, developing minimally invasive technologies with strong licensing potential. As one of the few Polish medtech companies on the WSE, it combines clinical expertise with a strategy focused on commercializing innovative solutions.
We Care About Your Privacy
Medinice S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.